Limited Value of Repeat Recombinant Human Thyrotropin (rhTSH)-Stimulated Thyroglobulin Testing in Differentiated Thyroid Carcinoma Patients with Previous Negative rhTSH-Stimulated Thyroglobulin and Undetectable Basal Serum Thyroglobulin Levels | Zendy

Maria Grazia Castagna | Zendy; Lucia Brilli | Zendy; Tania Pilli | Zendy; Annalisa Montanaro | Zendy; C. Cipri | Zendy; Carla Fioravanti | Zendy; Fausta Sestini | Zendy; Marco Capezzone | Zendy; Furio Pacini | Zendy

Open Access

Limited Value of Repeat Recombinant Human Thyrotropin (rhTSH)-Stimulated Thyroglobulin Testing in Differentiated Thyroid Carcinoma Patients with Previous Negative rhTSH-Stimulated Thyroglobulin and Undetectable Basal Serum Thyroglobulin Levels

Author(s) -

Maria Grazia Castagna,

Lucia Brilli,

Tania Pilli,

Annalisa Montanaro,

C. Cipri,

Carla Fioravanti,

Fausta Sestini,

Marco Capezzone,

Furio Pacini

Publication year - 2007

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2007-1404

Subject(s) - thyroglobulin , medicine , basal (medicine) , thyroid carcinoma , endocrinology , thyroid cancer , context (archaeology) , thyroid , urology , paleontology , insulin , biology

One year after initial treatment, low-risk differentiated thyroid cancer (DTC) patients undergo recombinant human (rh)TSH-stimulated serum thyroglobulin (Tg) (rhTSH-Tg) and neck ultrasound (US).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research